Further, cdc42 targeting results in a substantial reduction in Ras-mediated tumorigenesis as well as a reduction in the growth of established tumors, suggesting that Cdc42 activation by oncogenic Ras is crucial for Ras-mediated tumorigenesis and tumor maintenance. The gene discussed is CDC42; the disease is neoplasm.